| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 8,003 | 12,280 | 10,679 | 10,953 | | Cost of Revenue | 268 | 132 | 362 | 993 | | | Gross Profit | 7,735 | 12,148 | 10,317 | 9,960 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 1,643 | 1,603 | 1,649 | 1,221 | | Non Recurring |
-
|
-
|
-
| 5,231 | | Others | 1,817 | 2,186 | 2,352 | 2,496 | | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 4,275 | 8,359 | 6,316 | 1,012 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 85 | 179 | 28 | 46 | | Earnings Before Interest And Taxes | 4,052 | 8,686 | 6,504 | 1,234 | | Interest Expense | 3,110 | 3,631 | 4,094 | 4,835 | | Income Before Tax | 942 | 5,055 | 2,410 | (3,601) | | Income Tax Expense |
-
|
-
|
-
|
-
| | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | 1,391 | 5,055 | 2,410 | (3,601) | | | Non-recurring Events | | Discontinued Operations | 2,049 | (612) | 243 |
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 3,440 | 4,443 | 2,653 | (3,601) | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $3,440 | $4,443 | $2,653 | ($3,601) |
|
0.51% Nasdaq 
Income Statement
